Pub. Date : 2022 Jan
PMID : 35291604
7 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Background: This study evaluates the effect of simultaneous AKT inhibition and cisplatin therapy in changes of Reactive Oxygen Species (ROS) production, apoptosis induction, and cell survival in cisplatin-resistant OVCAR3 cell. | Cisplatin | AKT serine/threonine kinase 1 | Homo sapiens |
2 | Results: The results showed that all three treated groups, including cisplatin and Ly alone and co-administration of cisplatin+Ly, could reduce the cell vitality of OVCAR3 cancer cells, induced intracellular production of ROS and increased the expression level of activated caspase 3 and Akt protein, whereas down-regulated the phosphorylation of Akt protein. | Cisplatin | AKT serine/threonine kinase 1 | Homo sapiens |
3 | Results: The results showed that all three treated groups, including cisplatin and Ly alone and co-administration of cisplatin+Ly, could reduce the cell vitality of OVCAR3 cancer cells, induced intracellular production of ROS and increased the expression level of activated caspase 3 and Akt protein, whereas down-regulated the phosphorylation of Akt protein. | Cisplatin | AKT serine/threonine kinase 1 | Homo sapiens |
4 | Results: The results showed that all three treated groups, including cisplatin and Ly alone and co-administration of cisplatin+Ly, could reduce the cell vitality of OVCAR3 cancer cells, induced intracellular production of ROS and increased the expression level of activated caspase 3 and Akt protein, whereas down-regulated the phosphorylation of Akt protein. | Cisplatin | AKT serine/threonine kinase 1 | Homo sapiens |
5 | Results: The results showed that all three treated groups, including cisplatin and Ly alone and co-administration of cisplatin+Ly, could reduce the cell vitality of OVCAR3 cancer cells, induced intracellular production of ROS and increased the expression level of activated caspase 3 and Akt protein, whereas down-regulated the phosphorylation of Akt protein. | Cisplatin | AKT serine/threonine kinase 1 | Homo sapiens |
6 | Conclusion: The results showed that the AKT inhibition by Ly could sensitize the OVCAR3 cancer cells to the cisplatin and lower the effective dose of cisplatin through hyperactivation of oxidative stress. | Cisplatin | AKT serine/threonine kinase 1 | Homo sapiens |
7 | Conclusion: The results showed that the AKT inhibition by Ly could sensitize the OVCAR3 cancer cells to the cisplatin and lower the effective dose of cisplatin through hyperactivation of oxidative stress. | Cisplatin | AKT serine/threonine kinase 1 | Homo sapiens |